It didn’t make sense why TLOG would renegotiate. Now this news out of Medivir makes sense why they renegotiated and I my opinion this is an awful deal for shareholders. Is Mr. Alexandre Zyngier still the CEO and TLOG board? We now get payments of a payment because birinipant licensing has been reassigned. Maybe time shareholders seek outside assistance?